Clinical Trials Directory

Trials / Completed

CompletedNCT06781489

Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine.

Pain Reduction Caused by the Combined Treatment of Neural Mobilization, Oral Gabapentin and Oral Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
129 (actual)
Sponsor
Universidad Europea de Madrid · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In the present investigation the pain reduction effects of a physiotherapy technique combined with gabapentin and ibuprofen arginine will be compared to those produced by an ibuprofen arginine (only) treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.

Detailed description

The present randomized clinical trial will perform a comparison of (group 1) the pain reduction effects produced by the application of a non invasive and non pharmacological median nerve neural mobilization (physiotherapy treatment) combined with a pharmaceutical oral gabapentin treatment versus (group 2) median nerve neural mobilization (physiotherapy treatment) combined with a pharmaceutical oral ibuprofen arginine treatment, to those effects produced by (group 3) ibuprofen arginine (only) treatment. Additionally, effects over the functionality of the affected upper limb will be evaluated and compared. Subjects will be invited to participate and randomly allocated to 2 different groups.

Conditions

Interventions

TypeNameDescription
OTHERMedian nerve neural mobilizationManual therapy maneuver performed in the upper limb
DRUGGabapentin 300mgOral gabapentin capsule
DRUGIbuprofen ArginineOral ibuprofen arginine tablets

Timeline

Start date
2025-02-19
Primary completion
2025-03-20
Completion
2025-03-29
First posted
2025-01-17
Last updated
2025-12-11

Locations

1 site across 1 country: Venezuela

Source: ClinicalTrials.gov record NCT06781489. Inclusion in this directory is not an endorsement.